If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

Share Price is delayed by 15 minutes
Get Live Data
4,465.00    -45.00 (-1.00%)
Bid:
4,435.00
Ask:
4,445.00
Spread: 10.00 (0.225%)
Market Cap: £1.38b
CGEO Live PriceLast checked at - London Stock Exchange

Intraday Georgia Capital Share Chart

Directorate Change

17 Oct 2022 15:29

RNS Number : 1538D
Georgia Capital PLC
17 October 2022
 

London, 17 October 2022

 

 

Georgia Capital PLC announces a new appointment to its Board of Directors

Georgia Capital PLC ("Georgia Capital" or "the Group") announces a new appointment to the Board of Directors ("the Board") with immediate effect. Neil Janin has joined the Board as an independent non-executive director. Mr Janin has also been appointed as a member of the Remuneration and Nomination Committees and will join the Supervisory Board of JSC Georgia Capital.

Irakli Gilauri, Chairman and CEO of Georgia Capital, commented: "We are pleased to welcome Neil to our Board of Directors. Neil Janin has extensive experience of serving as a non-executive director of Georgian groups who are also listed on the London Stock Exchange. His career spans Europe, Asia and North America, across the retail, asset management and corporate banking industries, and all areas of organisational practice, including governance, culture, design, leadership, performance enhancement, change and transformation. Neil is bringing his considerable insight of international strategic and commercial practices, in addition to significant experience of governance and the Georgian investment climate, for the Group's future development."

 

 

Biography

 

Neil Janin has extensive experience as Non-Executive Director of Georgian groups that are also listed on the premium sector of the London Stock Exchange: he was Chair and Non-Executive Director of BGEO Group PLC from October 2011 until 21 May 2018 and of Bank of Georgia Group PLC from February 2018 until 10 March 2022, and he served as Non-Executive Director of Georgia Capital PLC's (then listed) subsidiary Georgia Healthcare Group PLC from September 2015 until 30 April 2018. He serves as counsel to CEOs of both for-profit and non-profit organisations and continues to provide consulting services to McKinsey & Company. Mr Janin was a Director of McKinsey & Company, based in its Paris office, for over 27 years, from 1982 until his retirement. At McKinsey & Company, he conducted engagements in the retail, asset management and corporate banking sectors, and was actively involved in every aspect of organisational practice, including design, leadership, governance, performance enhancement and transformation. Before joining McKinsey & Company, Mr Janin worked for Chase Manhattan Bank (now JP Morgan Chase) in New York and Paris, and Procter & Gamble in Toronto. Mr Janin has practised in Europe, Asia and North America. He is also a Director of Neil Janin Limited, a company through which he provides his ongoing consulting services. Neil Janin holds an MBA from York University, Toronto, and a joint honours degree in Economics and Accounting from McGill University, Montreal.

 

 

 

There are no other details that are required to be disclosed under 9.6.13 of the Listing Rules.

 

 

 

 

 

 

 

 

Name of authorised official of issuer responsible for making notification: Giorgi Alpaidze, Chief Financial Officer

About Georgia Capital PLC

Georgia Capital is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a retail (pharmacy) business, (ii) a hospitals business, (iii) an insurance business (P&C and medical insurance); (iv) a clinics and diagnostics business, (v) a renewable energy business (hydro and wind assets) and (vi) an education business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20% equity stake in the water utility business and a 20% equity stake in LSE premium-listed Bank of Georgia Group PLC ("BoG"), a leading universal bank in Georgia.

JSC Georgia Capital has, as of the date hereof, the following credit ratings:

S&P Global

'B+'/FC & 'B+'/LC

Moody's

B1/CFR & B1/PDR

 For further information, please visit www.georgiacapital.ge or contact:

 

Irakli Gilauri

Giorgi Alpaidze

Michael Oliver

Shalva Bukia

Chairman and Chief Executive

Chief Financial Officer

Adviser to the Chairman & CEO

Head of Investor Relations

ir@gcap.ge

+995 322 005 000

+44 203 178 4034

+ 995 322 005 045

ir@gcap.ge

ir@gcap.ge

ir@gcap.ge


This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZZMMGDNRGZZM
Date   Source Headline
17th May 202312:37 pmRNSResult of AGM
15th May 20235:29 pmRNSTransaction in Own Shares
11th May 20233:57 pmRNSTransaction in Own Shares
10th May 20235:25 pmRNSTransaction in Own Shares
10th May 20237:00 amRNS1st Quarter Results
5th May 20235:22 pmRNSTransaction in Own Shares
3rd May 20237:00 amRNSNotice of Results
2nd May 20234:57 pmRNSHolding(s) in Company
2nd May 20232:38 pmRNSTransaction in Own Shares
2nd May 202311:19 amRNSTotal Voting Rights
2nd May 20239:37 amRNSDirector/PDMR Shareholding
28th Apr 20234:52 pmRNSTransaction in Own Shares
28th Apr 20234:13 pmRNSCancellation of Treasury Shares
27th Apr 20234:38 pmRNSTransaction in Own Shares
26th Apr 20233:44 pmRNSTransaction in Own Shares
25th Apr 20235:32 pmRNSTransaction in Own Shares
24th Apr 20234:21 pmRNSTransaction in Own Shares
24th Apr 20233:34 pmRNSDirector/PDMR Shareholding
20th Apr 20235:34 pmRNSTransaction in Own Shares
19th Apr 20235:33 pmRNSTransaction in Own Shares
18th Apr 20235:49 pmRNSTransaction in Own Shares
14th Apr 20232:56 pmRNSHolding(s) in Company
14th Apr 202311:51 amRNSDirector/PDMR Shareholding
13th Apr 20235:39 pmRNSTransaction in Own Shares
13th Apr 20238:00 amRNSNotice of AGM
13th Apr 20237:00 amRNSTransfer to a Standard Listing on the LSE
12th Apr 20237:00 amRNSLaunch of US$ 10 million share buyback programme
11th Apr 20235:30 pmRNSGeorgia Capital
11th Apr 202311:20 amRNSDirector/PDMR Shareholding
3rd Apr 202312:50 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSUpdate on divestments from subscale businesses
27th Mar 20235:00 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSAnnual Financial Report
20th Mar 20231:16 pmRNSDirector/PDMR Shareholding
14th Mar 202312:36 pmRNSResult of Meeting
10th Mar 20233:23 pmRNSDirector/PDMR Shareholding
6th Mar 20233:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSEducation business continues to expand
28th Feb 20234:32 pmRNSHolding(s) in Company
27th Feb 20233:04 pmRNSDirector/PDMR Shareholding
20th Feb 20233:44 pmRNSDirector/PDMR Shareholding
20th Feb 20237:00 amRNSFinal Results
17th Feb 202310:33 amRNSNotice of GM
14th Feb 202311:00 amRNSNotice of Results
13th Feb 20234:15 pmRNSDirector/PDMR Shareholding
6th Feb 20233:37 pmRNSDirector/PDMR Shareholding
30th Jan 20235:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20235:16 pmRNSDirector/PDMR Shareholding
23rd Jan 20234:59 pmRNSDirector/PDMR Shareholding
20th Jan 20235:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.